Literature DB >> 29669016

Hemodynamic response to fluid removal during hemodialysis: categorization of causes of intradialytic hypotension.

Nathan W Levin1, Marcia H F G de Abreu2, Lucas E Borges2, Helcio A Tavares Filho2, Rabia Sarwar3, Surendra Gupta3, Tahir Hafeez3, Shaul Lev4, Caroline Williams3.   

Abstract

Background: Intradialytic hypotension is a clinically significant problem, however, the hemodynamics that underlie ultrafiltration and consequent hypotensive episodes has not been studied comprehensively.
Methods: Intradialytic cardiac output, cardiac power and peripheral resistance changes from pretreatment measurements were evaluated using a novel regional impedance cardiographic device (NICaS, NI Medical, Peta Tikva, Israel) in 263 hemodialysis sessions in 54 patients in dialysis units in the USA and Brazil with the goal of determining the various hemodynamic trends as blood pressure decreases.
Results: Hypotensive episodes occurred in 99 (13.5%) of 736 intra- and postdialytic evaluations. The hemodynamic profiles of the episodes were categorized: (i) The cardiac power index significantly decreased in 35% of episodes by 36%, from 0.66 [95% confidence interval (CI) 0.60-0.72] to 0.43 (95% CI 0.37-0.48) [w/m2] with a small reduction in the total peripheral resistance index. (ii) The total peripheral resistance index significantly decreased in 37.4% of episodes by 33%, from 3342 (95% CI 2824-3859) to 2251 (95% CI 1900-2602) [dyn × s/cm5 × m2] with a small reduction in the cardiac power index. (iii) Both the cardiac power index and total peripheral resistance index significantly decreased in 27.3% of episodes, the cardiac power index by 25% from 0.63 (95% CI 0.57-0.70) to 0.48 (95% CI 0.42-0.53) [w/m2] and the total peripheral resistance index by 23% from 2964 (95% CI 2428-3501) to 2266 (95% CI 1891-2642). Conclusions: The hemodynamic profiles clearly define specific hemodynamic mechanisms of cardiac power reduction and/or vasodilatation as underlying intradialytic hypotensive episodes. A reduction in cardiac power (reduction of both blood pressure and cardiac output) could be the result of preload reduction due to a high ultrafiltration rate with not enough refilling or low target weight. A reduction in peripheral resistance (reduction in blood pressure and increase in cardiac output) could be the result of relative vasodilatation as arteries do not contract to compensate for volume reduction due to autonomous dysfunction. As both phenomena are independent, they may appear at the same time. Based on these results, a reduction of ultrafiltration rate and an increase in target weight to improve preload or immediate therapeutic actions to increase peripheral resistance are rational measures that could be taken to maintain blood pressure and prevent hypotensive ischemic complications in dialysis patients.

Entities:  

Mesh:

Year:  2018        PMID: 29669016     DOI: 10.1093/ndt/gfy048

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  13 in total

1.  Relative blood volume monitoring in hemodialysis patients: identifying its appropriate role.

Authors:  Peter Noel Van Buren
Journal:  Nephrol Dial Transplant       Date:  2019-08-01       Impact factor: 5.992

Review 2.  Intradialytic Hypotension: Mechanisms and Outcome.

Authors:  Benedict Sars; Frank M van der Sande; Jeroen P Kooman
Journal:  Blood Purif       Date:  2019-12-18       Impact factor: 2.614

3.  The Prevalence of Intradialytic Hypotension in Patients on Conventional Hemodialysis: A Systematic Review with Meta-Analysis.

Authors:  Johanna Kuipers; Loes M Verboom; Karin J R Ipema; Wolter Paans; Wim P Krijnen; Carlo A J M Gaillard; Ralf Westerhuis; Casper F M Franssen
Journal:  Am J Nephrol       Date:  2019-05-24       Impact factor: 3.754

4.  The associations between orthostatic blood pressure changes and extracellular volume in hemodialysis patients.

Authors:  Haekyung Jeon-Slaughter; Lucile Parker Gregg; Michael Concepcion; Swati Lederer; Jeffrey Penfield; Peter Noel Van Buren
Journal:  Hemodial Int       Date:  2021-08-16       Impact factor: 1.812

5.  Timing of Antihypertensive Medications on Key Outcomes in Hemodialysis: A Cluster Randomized Trial.

Authors:  Tara I Chang; Emily Tamar Tatoian; Maria E Montez-Rath; Glenn M Chertow
Journal:  Kidney360       Date:  2021-09-16

6.  Effect of hemodialysis on impedance cardiography (electrical velocimetry) parameters in children.

Authors:  Meike Wilken; Jun Oh; Hans O Pinnschmidt; Dominique Singer; Martin E Blohm
Journal:  Pediatr Nephrol       Date:  2019-12-14       Impact factor: 3.714

7.  Assessing accuracy of estimated dry weight in dialysis patients post transplantation: the kidney knows best.

Authors:  Michael J Germain; Barbara A Greco; Spencer Hodgins; Bikash Chapagain; Ravi Thadhani; David Wojciechowski; Kerry Crisalli; Brian H Nathanson; Yossi Chait
Journal:  J Nephrol       Date:  2021-05-24       Impact factor: 3.902

8.  The value of non-invasive measurement of cardiac output and total peripheral resistance to categorize significant changes of intradialytic blood pressure: a prospective study.

Authors:  Yunlin Feng; Yurong Zou; Yifei Zheng; Nathan W Levin; Li Wang
Journal:  BMC Nephrol       Date:  2018-11-06       Impact factor: 2.388

9.  Non-invasive hemodynamic profiling of patients undergoing hemodialysis - a multicenter observational cohort study.

Authors:  Keren Doenyas-Barak; Marcia H F G de Abreu; Lucas E Borges; Helcio A Tavares Filho; Feng Yunlin; Zou Yurong; Nathan W Levin; Allen M Kaufman; Shay Efrati; David Pereg; Ilya Litovchik; Shmuel Fuchs; Sa'ar Minha
Journal:  BMC Nephrol       Date:  2019-09-03       Impact factor: 2.388

10.  Long-Term Peridialytic Blood Pressure Patterns in Patients Treated by Hemodialysis and Hemodiafiltration.

Authors:  Paul A Rootjes; Camiel L M de Roij van Zuijdewijn; Muriel P C Grooteman; Michiel L Bots; Bernard Canaud; Peter J Blankestijn; Frans J van Ittersum; Francisco Maduell; Marion Morena; Sanne A E Peters; Andrew Davenport; Robin W M Vernooij; Menso J Nubé
Journal:  Kidney Int Rep       Date:  2020-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.